Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • IT / Health Venture
    • Apervita Selected by...

    Apervita Selected by GE Healthcare to Help Expand its Advanced Analytics Footprint

    Written by savita thakur thakur Published On 2016-03-01T12:36:00+05:30  |  Updated On 1 March 2016 12:36 PM IST
    Apervita Selected by GE Healthcare to Help Expand its Advanced Analytics Footprint
    CHICAGO: Apervita, Inc., the fastest growing platform and marketplace for creating, distributing and scaling health analytics and data, announced GE Healthcare is working with Apervita to make its advanced analytics application DenialsIQ™ available through the Apervita marketplace.

    As an international leader with extensive global research capabilities, GE Healthcare has built one of the world's largest portfolios of executable health analytics, many of which can be applied to improve health. GE has leveraged its Global Research capability to unlock new value for customers across industries. In one example, GE Healthcare repurposed an anomaly detection algorithm used to predict the need for jet engine maintenance to help identify millions of dollars' worth of hidden claims denials for healthcare organizations. DenialsIQ is an advanced analytics solution from GE Healthcare that uses a powerful statistical algorithm to uncover hidden patterns from within claims denials helping health enterprises improve financial performance by accelerating the recovery of revenues, reducing costly re-work, and avoiding future denials before they occur.

    "GE Healthcare and Apervita are working closely to bring DenialsIQ to the Apervita marketplace, and it's a good illustration of how GE Healthcare partners to deliver greater value for its customers. We are excited about the opportunity to generate new financial insights with DenialsIQ and Apervita," said Jon Zimmerman, Vice President and General Manager at GE Healthcare.

    "GE Healthcare is a pioneer in applying advanced analytics that go beyond traditional business intelligence," said
    Paul Magelli
    , Chief Executive Officer of Apervita. "We're very excited about the possibilities for GE and others to improve healthcare outcomes by enabling their customers with broad access to these world-class analytics through the Apervita platform and marketplace. By harnessing research advances across many industries, GE Healthcare has developed analytics and prediction tools that could help accelerate problem-solving for health enterprises," Magelli continued. "The power of Apervita comes into its own by enabling GE Healthcare to distribute advanced analytics to provider and payer systems as well as delivering leading analytics within their own products."
    ApervitaDenialsIQGE HealthcareJon ZimmermanPaul Magelli
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok